Overview

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Twelve smoking and twelve non-smoking subjects with Type 2 Diabetes Mellitus will be enrolled in this study to determine the effect of Technosphere® Insulin Inhalation Powder on insulin in the body during a clamp procedure.
Phase:
Phase 2
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin, Globin Zinc